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A Case of Myxedema Coma Presenting as a Brain Stem Infarct  
in a 74-Year-Old Korean Woman  
Myxedema coma is the extreme form of untreated hypothyroidism. In reality, few patients 
present comatose with severe myxedema. We describe a patient with myxedema coma 
which was initially misdiagnosed as a brain stem infarct. She presented to the hospital with 
alteration of the mental status, generalized edema, hypothermia, hypoventilation, and 
hypotension. Initially her brain stem reflexes were absent. After respiratory and circulatory 
support, her neurologic status was not improved soon. The diagnosis of myxedema coma 
was often missed or delayed due to various clinical findings and concomitant medical 
condition and precipitating factors. It is more difficult to diagnose when a patient has no 
medical history of hypothyroidism. A high index of clinical suspicion can make a timely 
diagnosis and initiate appropriate treatment. We report this case to alert clinicians 
considering diagnosis of myxedema coma in patients with severe decompensated 
metabolic state including mental change. 
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CASE REPORT
Emergency & Critical Care Medicine
INTRODUCTION
Myxedema coma represents an extreme form of hypothyroid-
ism and is associated with a high mortality rate (up to 60%) (1, 
2). This rare clinical state presents as a life-threatening decom-
pensated state that may include altered mental status, hypo-
thermia, bradycardia, hypoventilation, and cardiovascular col-
lapse (1-3). Coma results from either hypothyroidism or as a 
complication of hypothyroidism. In reality, few patients present 
as comatose with severe myxedema. Here we report a case of 
myxedema coma presenting with a severe decompensated met-
abolic state.
CASE REPORT
A 74-yr-old woman was transferred to our emergency depart-
ment from the local general hospital with an initial diagnosis of 
brain stem infarct on January 17, 2009. The patient was found 
unconscious and in a bed-ridden state during the early morn-
ing on the presenting day. The patient’s breathing was shallow 
and irregular. The patient was unable to walk well due to a coc-
cyx fracture two years ago, but she was able to perform daily life 
activities with minor help. One week ago, her facial edema start-
ed and she complained dry cough and general weakness three 
days ago. No other medical, familial, or social history was report-
ed, and the patient had not taken any medication. There was 
also no evidence of intoxication. 
  According to the records of the local general hospital, the pa-
tient had an impending respiratory arrest and comatose mental 
status. Her blood pressure was 71/48 mmHg, her body temper-
ature was 36.0°C, and her pulse rate was 99 beats/min with a si-
nus rhythm by electrocardiography (ECG). Neurologic examina-
tion revealed pinpoint pupils and a lack of brain stem reflexes, 
including the light reflex, corneal reflex, gag reflex, and doll’s-eye 
phenomenon. She also showed decerebrated rigidity in response 
to painful external stimuli. The patient was assigned a score of 5 
on the Glasgow Coma Scale, and the Babinski sign was detected 
at both feet. Brain computed tomography (CT) produced unre-
markable results. Endotracheal intubation was performed for 
protection of the patient’s airway, assisted ventilation was initi-
ated, and an inotropic agent was injected to support the patient’s 
state of shock, which did not respond to fluid therapy (1 L of nor-
mal saline). Prior to transfer, the patient’s blood pressure was 
increased, but her neurologic findings were not improved. She 
was transferred to our hospital for further evaluation and treat-
ment of a brain stem infarct. 
  On arrival, the patient’s blood pressure was 70/40 mmHg, her 
pulse rate was 59 beats/min, and an intravenous infusion of pre-
mixed dopamine was administered (500 mL/800 mg, 20 μg/kg/
min). The patient’s body temperature was 34.8°C according to a 
tympanic membrane thermometer, and her self-respiration was 
slow and shallow. The patient’s lungs on auscultation were bilat-
erally clear, and cardiac examination showed a regular rate and 
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men was soft without signs of guarding, tenderness, or rebound 
tenderness. A rectal examination revealed no masses, and the 
patient’s stool was guaiac negative. No soiling due to urine or 
feces was noted on her undergarments. 
  The patient’s face and extremities were edematous, and she 
presented with non-pitting edema. Her skin was dry, cool, pale, 
and slightly mottled and desquamated; however, there was no 
evidence of petechiae or purpura (Fig. 1).
  The patient’s level of consciousness was stupor to semi-coma. 
A neurologic examination revealed intact cranial nerves and she 
didn’t show lateralizing signs. The patient’s pupils were 3 mm 
across and briskly reactive. It was impossible to check for visual 
abnormalities and focal cerebellar findings. The results of the 
Babinski reflex test were negative. 
  The patient’s laboratory values were as follows: WBC count 
6,000/μL (86% neutrophils), hemoglobin 11.8 g/dL, sodium 121 
mEq/L, potassium 4.2 mEq/L, chloride 87 mEq/L, BUN 1.3 mg/ 
dL, creatinine 0.6 mg/dL, glucose 104 mg/dL, ALT 113 U/L, AST 
74 U/L, albumin 3.3 g/dL, CK 499 IU/L, CK-MB 21.4 ng/mL, tro-
ponin-I <0.02 ng/mL, lactate 1.2 mM/L, urine RBCs 1-4/HPF, 
and urine WBCs 0-1.5/HPF. Arterial blood gas analysis (FiO2 
1.0) revealed a pH of 7.486, a pCO2 of 30.6 mmHg, a pO2 of 36.4 
mmHg, a HCO3
- concentration of 22.9 mM/L, and an oxygen 
saturation of 77%. 
  A portable chest radiography revealed infiltration of the right 
Fig. 1. The gross photos of patient’s face and extremities. (A, B) Severe periorbital edema and thinned eyebrow. (C, D) Non-pitting edema and desquamation of the hands and feet.   
A B
C D
Fig. 2. Initial ECG showed sinus bradycardia (ventricular rate 59/min), low QRS vol-
tage, and a prolonged QT interval (QTc >470 ms). Ahn JY, et al.  •  A Case of Myxedema Coma Presenting as a Brain Stem Infarct 
1396   http://jkms.org DOI: 10.3346/jkms.2010.25.9.1394
lower lung zone and cardiomegaly. ECG revealed sinus brady-
cardia with no evidence of ischemia; the intervals and axis were 
normal except for a prolonged QTc interval. Echocardiography 
revealed a small amount of pericardial effusion, but it did not 
affect the patient’s hemodynamic status. 
  During our resuscitative efforts, the patient’s blood pressure 
didn’t respond and additional laboratory test results confirmed 
hypothyroidism. The patient’s free thyroxine was 0.05 ng/dL 
(0.93-1.7) and her TSH was 30.12 μIU/mL (0.27-5.0). A diagno-
sis of myxedema coma exacerbated by community-acquired 
pneumonia was thus assigned.
  The patient was referred to the Department of Endocrinology 
and admitted to the intensive care unit for treatment and venti-
latory support. The patient received 1,000 μg of levothyroxine 
orally for two days, followed by 300 μg/day for an additional three 
days and finally maintained on levothyroxine 0.1 mg orally each 
day. Following the administration of synthetic thyroid hormones 
for hypothyroidism and antibiotics for pneumonia, the patient 
regained consciousness and respiration. She was transferred to 
a general ward after two weeks in the intensive care unit and dis-
charged from the hospital one week later. 
 
DISCUSSION
The patient’s initial presenting conditions, which were misdiag-
nosed as a brain stem infarct at the local general hospital, may 
have been due to low blood perfusion to her brain. Comas are 
caused by a wide variety of disorders, ranging from structural 
central nervous system problems to diffuse systemic disease. 
Approximately 15% of coma cases are caused by structural le-
sions (1, 2). According to the records of the local general hospi-
tal, the patient’s major brain stem reflexes were absent both ini-
tially and after their attempts at resuscitation; however, her neu-
rologic status improved following our resuscitative efforts, so 
shock was our main concern. Septic shock due to pneumonia 
was the initial diagnosis; however, the patient was relatively un-
responsive to our treatment efforts and her heart rate was slow 
despite the fact that her blood pressure was low. The patient’s 
compensatory mechanisms were therefore not working and her 
clinical presentation was one of a severe decompensated meta-
bolic state. She showed typical non-pitting edema, especially 
on the face and the result of routine laboratory test like albumin 
didn’t explain the cause of her edema; therefore, we considered 
the diagnosis of myxedema and ordered thyroid and adrenal 
function tests. 
  Myxedema coma is a life-threatening form of hypothyroidism 
with physiological decompensation, including mental changes 
(1-4). Myxedema coma is 4-8 times more common in women, 
and such patients show an altered mental status, including leth-
argy, stupor, delirium, or coma. Secondary insults such as cli-
mate-induced hypothermia, infection, additional systemic con-
ditions, or drug therapy can worsen the patient’s condition. The 
patient presented at our hospital with diffuse edema especially 
face and extremities, alterations in mental status, hypothermia, 
hypoventilation, hypotension, and bradycardia. The clinical pre-
sentation was one of a severe decompensated metabolic state 
(1). The habitus of a myxedema comatose patient is character-
istic and usually recognizable; however, hypothermia and a de-
pressed mental state are often seen in other conditions, which 
may be mistaken for hypothyroidism. Sepsis and accidental hy-
pothermia, for example, may mimic hypothyroidism (2). In ad-
dition to physiologic decompensation, the patient showed gen-
eralized nonpitting edema. Facial edema started one week from 
the presenting date and progressed to all extremities. Her ede-
ma was most prominent at the periorbital area and her conjunc-
tivae were also swollen. The patient’s skin was smooth, dry, des-
quamated, and cool. Congestive heart failure or nephrotic syn-
drome with renal failure may initially be confused with myxede-
ma coma due to generalized edema. However, generalized non-
pitting edema, particularly with a periorbital distribution, is typ-
ical. Edema is secondary to hyaluronic acid deposition and is 
not characteristically seen initially in dependent areas (2). Simi-
lar to the patient described, laboratory evaluations may reveal 
anemia, hyponatremia, hypoglycemia, arterial blood gas abnor-
Fig. 3. Chest X-rays. (A) Initial chest X-ray revealed cardiomegaly and infiltration of 
the left lower lung zone. (B) Follow-up X-ray showed an improved state.
A B
A B
Fig. 4. Echocardiography. Parasternal long axis view (A) and apical four chamber view 
(B) revealed a moderate amount of pericardial effusion without hemodynamic signifi-
cance; effusion was localized to the right atrium. Ahn JY, et al.  •  A Case of Myxedema Coma Presenting as a Brain Stem Infarct
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malities, and elevated levels of transaminases, creatine phos-
phokinase, and lactate dehydrogenase. ECG may demonstrate 
sinus bradycardia, prolongation of the QT interval, and low volt-
age. Chest radiography may demonstrate an increased cardiac 
contour due to pericardial effusion (1, 5).
  Poor prognostic factors include persistent hypothermia that 
is unresponsive to 72 hr of therapy, advanced age, bradycardia 
(<44 beats per min), sepsis, myocardial infarction, and hypoten-
sion. Predictive values of survival are the patient’s level of con-
sciousness at admission and his/her score on the Glasgow Coma 
Scale and on the Acute Physiology and Chronic Health Evalua-
tion (APACHE) II (6). The three principles of management are 
rapid institution of thyroid hormone replacement, treatment of 
the precipitating cause, and the provision of ventilatory support 
(1, 5).
  Missing a diagnosis of myxedema coma is a major cause of 
increased mortality. Despite readily available, sensitive thyro-
tropin assays, however, the recognition and treatment of myx-
edema coma remains a challenge. 
  Hypothyroidism in adults most frequently causes dementia 
and depression. Other less common clinical symptoms include 
myxedema coma and dysfunction of the cerebellum and cranial 
nerves. Hypothyroidism also increases one’s risk of stroke. Pe-
ripheral diseases frequently include polyneuropathy, carpal tun-
nel syndrome, a myalgic state, and, rarely, myokymia. In partic-
ular, little is known regarding the underlying pathology of cog-
nitive impairment and depression in hypothyroidism, which 
may differ from that seen in euthyroid patients. About 40% of 
hypothyroid patients have signs of sensorimotor axonal neurop-
athy early in the course of the disease. Little is known about the 
reversibility of changes in cerebral blood flow following thyroid 
replacement therapy (7, 8). 
  As considered patient’s age and cardiovascular risks, the pa-
tient was dosed 1,000 μg of levothyroxine orally for two days, 
followed by 300 μg/day for an additional three days and finally 
maintained on levothyroxine 0.1 mg orally each day. Like this 
patient, prompt thyroid hormone replacement is critical for pa-
tient survival from myxedema coma, although the most effec-
tive regimen is unclear. The most widely published approach to 
myxedema coma involves the intravenous administration of T4 
or T3 in a dose of 300 to 500 μg that depends on patient weight 
and cardiac risks. It is suggested that this dose replaces total body 
stores of T4, and the pool can be maintained by 50 to 100 μg/day 
(2). There were no available IV drugs in our hospital, so we ad-
ministered higher dose (double dose) of oral regimen. For elderly 
and patients with cardiac comorbidity, the use of T4 alone should 
be considered. For critically ill younger patients without cardiac 
disease, where a more rapid correction of hormone levels is de-
sired, the use of T3 alone should be considered (2). A recent case 
showed that a young patient who was treated successfully with 
a large oral dose (triple dose) of levothyroxine (9). 
  When assessing a patient, even if there are physical findings of 
stroke or other neurologic diseases, endocrinal problems must 
be considered. These include not only diabetes, adrenal disor-
ders, and pituitary disorders, but also thyroid disorders. Thyroid 
disorders must be ruled out, even though they are very rare. If 
such conditions are not considered, the survival rate will be low.  
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